DEBORAH MASTRIANI: Open Payments
NPI 1972547495 · WATERBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$833 in 19 payments from 8 companies in 2025. Trend: 2023 $721 · 2024 $441 · 2025 $833
Food & beverage: $833
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 3 | $180 |
| Optinose US, Inc. | 2 | $151 |
| Galderma Laboratories, L.P. | 1 | $132 |
| AstraZeneca Pharmaceuticals LP | 1 | $130 |
| GlaxoSmithKline, LLC. | 4 | $89 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $86 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| Stryker Corporation | 1 | $14 |
Products named: INSPIRE, Xhance, NEMLUVIO, TEZSPIRE, NUCALA, NEFFY, DUPIXENT, XPRESS LOPROFILE.
Industry payments across CT — which companies pay providers there.
